HOME ABOUT PRODUCTS JOIN US CONTACT Innovation through research, technology, and ingenuity Our Legacy. The original MC3 was founded in 1991 by Robert Bartlett M.D. and Scott Merz PhD as a spin-off from the University of Michigan. For over 20 years the Company developed intellectual property related to extracorporeal artificial hearts and lungs while contributing important translational research to the extracorporeal life support community. In 2013 Robert Foster, acquired the company and formed the new MC3 Cardiopulmonary, turning the small research group into a commercially focused ECMO and related device manufacturer. Our Purpose. MC3 Cardiopulmonary believes in purposeful innovation. Our mission is to serve the global community by creating life restoring medical devices that address acute and chronic unmet cardiopulmonary clinical needs. Advances in Extracorporeal Membrane Oxygenation (ECMO) make it one of the most advanced life support technologies in existence for patients failing traditional therapies such as the ventilation. ‍MC3, together with the ECMO Community, is working to transform healthcare by delivering ECMO to patients suffering from acute respiratory and cardiac failure across a broad therapy spectrum. Management Team Catherine Schmidt Chief Financial Officer Catherine Schmidt, Chief Financial Officer, is an accomplished financial executive with 25+ years in public and private accounting. Catherine began her executive career at Arthur Anderson and has worked as the Chief Financial Officer for several companies within the healthcare, software, and automotive industries. Scott Merz President & CEO, Co-founder Scott Merz, PhD., Chief Executive Officer and Co-Founder, has 25+ years of experience in medical device research, development, and business formation. Scott holds 10+ patents and has led numerous licensing deals enabling the launch of several spinout device companies. He is a charter member of the Extracorporeal Life Support Organization (ELSO) and long-standing leader of the cardiopulmonary community. Bill Sidor Vice President Engineering Bill Sidor, VP Engineering, has 30+ years of experience in medical device development, having introduced numerous surgical products during his tenure of management at DLP, Medtronic, and Avalon Laboratories. Martha Rumford Director of Regulatory Affairs and Quality Martha Rumford, Director of Regulatory Affairs and Quality, has 25+ years experience in the areas of cardiopulmonary bypass disposables, heparin coatings, heart-lung machines, and active implantable heart assist devices. Martha’s experience includes regulatory submissions, risk management, quality planning, and technology transfer. She has held leadership positions at Becton Dickenson, Terumo, and 3M. Rio Foster Vice President Sales & Marketing Rio Foster, VP Sales and Marketing, has medical device expertise focused on launching innovative products and therapy strategies through a deep understanding of customer-focused insights, business strategy, and process. Prior to MC3, he worked at Maquet Cardiovascular and Avalon Laboratories. Ted Chittenden Vice President Operations & Manufacturing Ted Chittenden, VP Operations, has vast experience with sterile disposables manufacturing and executive management, including previous leadership positions at Surge Cardiovascular, Cascade Engineering, and Medtronic. Board of Directors Robert Foster Chairman of the Board Robert Foster, Board Chairman, has 30+ years in the medical device industry. Robert founded Avalon Laboratories in 1990 and grew it into the world’s largest surgical cannula OEM manufacturer before selling it in 2008. He acquired a majority share of MC3 in 2013 and provides visionary leadership to the executive team. Rio Foster Vice President Sales & Marketing Rio Foster, VP Sales and Marketing, has medical device expertise focused on launching innovative products and therapy strategies through a deep understanding of customer-focused insights, business strategy, and process. Prior to MC3, he worked at Maquet Cardiovascular and Avalon Laboratories. Scott Merz President & CEO, Co-Founder Scott Merz, PhD., Chief Executive Officer and Co-Founder, has 25+ years of experience in medical device research, development, and business formation. Scott holds 10+ patents and has led numerous licensing deals enabling the launch of several spinout device companies. He is a charter member of the Extracorporeal Life Support Organization (ELSO) and long-standing leader of the cardiopulmonary community. John Mack Vice President & General Manager of Medtronic Cardiac Surgery John is the Vice President and General Manager of the Cardiac Surgery business. Medtronic's Cardiac Surgery business includes Cardiopulmonary, Blood Management, Cannula, MICS, OpCab, Ablation, Surgical Heart Valves and Repair. John has been with Medtronic for over 23 years and in the Structural Heat/Cardiac Surgery business since 2000. John has held a series of roles in Finance, Marketing, Business and Corporate Development. He is a past recipient of both the Wallin Leadership Award and the Medtronic Star of Excellence Award. Christopher Ball Managing Director, Critical Point Partners Christopher Ball, Board Member, is Managing Director of Critical Point Partners in Manhattan Beach, CA. Chris spent the first 15 years of his career developing safety-critical products for TRW and International Rectifier. Bill Sidor Vice President Engineering Bill Sidor, VP Engineering, has 30+ years of experience in medical device development, having introduced numerous surgical products during his tenure of management at DLP, Medtronic, and Avalon Laboratories. Contact Us MC3 Cardiopulmonary 2555 Bishop Circle W. Dexter, MI 48130 info@mc3corp.com 1 734.995.9089 ADDRESS MC3 Cardiopulmonary 2555 Bishop Circle W. Dexter, MI 48130 PHONE +1 734.995.9089 EMAIL info@mc3corp.com © 2020 MC3 Cardiopulmonary